Archive for the ‘ALR Technologies Inc. ALRT’ Category

Stock Guru Featured Company: ALR Technologies, Inc. (ALRT.OB)

Tuesday, June 3rd, 2008

ALR Technologies, Inc. (ALRT.OB) primarily engages in designing, marketing, and distributing medical reminder compliance devices. The company uses technology-based products that aid people in achieving improved health and well-being. ALR Technologies is known as a pioneer in the compliance management sector of the disease management industry.

ALR Technologies is focused on providing a product that reminds patients to take their medication or treatment at the prescribed time. The company offers ALRT Med Reminder, ALRT Once-A-Day, ALRT Weekly, ALRT Contact Lens Replacement and ALRT PC200. Each product can be programmed by the user for specific time-duration reminders. The company’s well-known product, Constant Health Companion, reminds the user of the time to take medication and displays the actions or medications necessary to that specific reminder. ALR Technologies’ product offering ranges from portability, display on LCD screens, and pet medication reminders.

ALR Technologies is based in Winston-Salem, North Carolina and is focused on marketing their products in the United States. The company specifically markets their products to disease management companies, health insurance providers, pharmaceutical manufacturers, retail pharmaceutical chains, and distribution companies for resale to independent pharmacies.

Let us hear your thoughts: ALR Technologies, Inc. Message Board

AllPennyStocks Featured Company: ALR Technologies, Inc. (ALRT.OB) Introduces New Product and Builds into the Future

Thursday, January 31st, 2008

Becoming a leader in the health sector, especially in cancer and diseases, ALR Technologies, Inc. (OTCBB: ALRT) has dedicated itself in keeping tabs on the health of individuals between visits to the doctor or hospital. With their flagship product, the Constant Health Companion™, the company designs and manufactures health management compliance products along with monitoring and intervention systems to better serve individuals suffering from illnesses.

The Constant Health Companion™ properly alerts doctors when their patients aren’t taking their prescribed medications correctly and at the appropriate time. The device is portable and has the benefits of easy configurations.

It may be surprising to know that more than $150 billion a year is contributed to non-adherence of treatments, and in preventable excess health-care costs. ALR hopes to have a significant and positive impact on these preventable costs. A recent research report by Forrest Research projected the home health technology market to grow to $5 billion within two years and $35 billion by 2015.

Last November the company successfully completed software enhancements on the Constant Health Companion™ which resulted in patent applications to be fielded for expanded intellectual property. The company marketed to 50 employer-led coalitions representing tens of thousands of companies that sponsor self-insured health benefits to more than 30 million employees and their dependents. Individuals who are stricken with one or more chronic diseases will be the initial users.

The company has been extremely active in research and development, which shows on their updated company figures. With administrative costs and new funding in research and development the company saw their numbers sink more than a million in the hole in 2006. Although that was the case, ALRT’s ambition to innovate and produce new products has investors keeping a close eye on the proceedings.

The stock is itching to break out past its 52-week peak of 25 cents achieved in early December 07, after plumbing a depth of four cents at the end of March 07. But uncertainty gripped the market at both ends of the spectrum, and small caps like ALRT were not immune. Towards the end of January, the price was around 15 cents. But with the attraction ALRT’s monitoring system holds for more health-care professionals, the company’s fortunes are to be watched, much as the devices watch our health.

Let us hear your thoughts below:

Small Cap Voice Featured Client: ALR Technologies, Inc. (ALRT.OB)

Monday, December 10th, 2007

ALR Technologies, Inc. is focused on designing, marketing, and distributing technology-based products to help people achieve better health and well-being. Their products include Medication Administration Reminders that help enhance the medication’s therapeutic benefit by improving compliance.

The company is a pioneer in the growing markets of home health management and disease management. Although medical researchers and pharmaceutical companies have been successful creating treatments to manage diseases and health issues, the treatments are ineffective if there is poor medication compliance at home.

The emerging issue of patients incorrectly following medication directions contributes to more than $140 billion annually in unnecessary heath care costs. Healthcare costs alone account for more than 15% of U.S. gross domestic product and is projected to reach 25% by 2020, offering companies such as ALR Technologies a great opportunity to capitalize in the emerging market.

Let us hear your thoughts: ALR Technologies, Inc. Message Board

Alert Technologies, Inc. (ALRT.OB) and Mail Meds Team Up to Offer Medication Adherence system

Wednesday, November 28th, 2007

Today, Alert Technologies announced Mail Meds will use its disease management program to supply a CHC(TM) system to Medicare patients. This is momentous as non adherence costs $150 billion a year in preventable healthcare costs. Mail Med is also a provider of drug adherence systems through their Med Box(TM) and Personalized Pill Box system.

Based out of Fort Myers, Fl Mail Meds specializes in simplifying medication regimes for the chronically ill. They help patients with Diabetes, Heart Failure, HIV/AIDS and mental health issues. Mail Meds provides these adherence systems and medication regimes to (SNP’s) and assisted living homes.

The CHC(TM) system by Alert Technologies is targeted at Home patients that alerts patients when they have failed to take a needed medication. This market according to a recent research report from Forrester Research, Inc. is to grow to $5 billion by 2010 and then to $35 billion by 2015. CHC also addresses the need for constant monitoring in healthcare management. This enables the healthcare provider to remotely monitor patients and provide timely assistance when needed. Alert’s CHC system costs 30% less and provides more features than any other available substitute. Alert Technologies goal is to have the International Healthcare Industry consider the CHC system as the standard operating procedure.

Mail Meds is providing the CHC system to their patients at no added costs to qualified patients. Currently there is 40 million Medicare and 46 million Medicaid patients and these numbers are expected to rises as Baby Boomers continue to age. This is creating an even greater need for Alert’s CHC™ system. v President and CEO of Mail-Meds, Mark Jay Theobald, is quoted saying, “We are pleased to offer this service to qualified patients, where medication adherence is critical to maintaining their health. The combination of the CHC and the Mail-Meds Med-Box(TM) will address the major issues driving non-adherence. Our mission is to be the industry leader in improving medication adherence for chronically ill patients. Our total service package will improve health outcomes for these patients and reduce the escalating healthcare costs.”

Let us hear your thoughts below:

StockGuru Blog: ALR Technologies Exclusive System — Great for Business; The Only Monitoring System Available for Chronic Obstructive Pulmonary Disease – COPD

Friday, November 24th, 2006
ALRTALR Technologies, Inc.
Stock Guru Profile ALR Technologies Inc. (ALRT – OTCBB)

Chronic obstructive pulmonary disease also called COPD, is a chronic lung disease that includes two main illnesses: chronic bronchitis and emphysema. ALRT has the only nebulizer monitoring system in the world. ALRT is directing its marketing efforts to this segment of the healthcare industry. One percent of the four million users of nebulizers would generate revenues of $19 million with a gross profit margin of approximately $14 million.

Considerable focus is being placed on the respiratory market due to the large number of people suffering from COPD who may have need for the ALRT nebulizer compliance and monitoring system.

There is no cure for COPD. This is a chronic and progressive disease which impacts the quality of a person’s life and activities in a dramatic fashion. Studies have indicated that it is not uncommon to find diagnosis of anxiety, depression and dyspnea associated with COPD. These associated issues such as depressions and anxiety are examples of the subtle but very real indicators which create barriers to medication compliance.


With the only nebulizer compressor monitoring system in the world ALR Technoligies’ system enables physicians and caregivers to monitor the patients or caretakers use of the nebulizer; the time of day used and the duration of time used. This monitoring is especially important to the millions of people who suffer from COPD and have to take nebulized medications daily. The system consists of the ALRT PC500 connected to nebulizer models that include the connectivity and a transmission modem. ALR Technologies has patents pending for this system.

Agreements have been reached with nebulizer manufacturers to produce nebulizer models containing the ALRT monitoring connectivity. An agreement with a specialty marketing company serving the respiratory market was completed that will provide access to the major respiratory marketing and provider companies.

Major home care networks are being targeted by the marketing company and the nebulizer manufacturers as channels of choice in providing the ALRT nebulizer compliance and monitoring system to physicians and their patients.

The respiratory market includes more than 16 million people with COPD. One of the methods for treating COPD is by inhaling drugs that are delivered through nebulizers, special machines that aerosolize drugs diluted in normal saline to permit easier inhalation into the lungs. There are four million nebulizer users who use nebulizers to deliver medication to their lungs three to four times every day. Nebulizer compliance is essential for maintaining quality of life and preventing rapid deterioration.

ALR Technologies Power Point Presentation.

Page Minder Report

Source: ALR Technologies

Wendy Prabhu, Investor Relations for ALR Technologies, Inc.
Phone: (512) 828-6645
Email: http://www.stockguru.com/blog/alrt@mercomcapital.com

Sidney Chan, CEO
ALRTALR Technologies, Inc.
114M Reynolda Village
Winston-Salem, NC 27106
Website: http://www.alrt.com
Phone: (336) 722-2254

SOURCE: ALR Technologies, Inc. and New England Journal of Medicine and Managed Healthcare Executive; Sep2006, Vol. 16 Issue 9, p44-51, 4p

Safe Harbor and Forward Looking Statement:Certain statements set forth in this article constitute “forward-looking statements.” Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance or achievements. Such statements are not guarantees of future performance and are subject to risks and uncertainties that could cause the company’s actual results and financial position to differ materially from those included within the forward-looking statements, including the Company’s ability to obtain sufficient financing to fund both its internal growth opportunities and acquisition strategy. More information about the potential risks and factors that could affect the Company’s business and financial results is included in the Company’s filings, available via the United States Securities and Exchange Commission at http://www.sec.gov/.

Disclosure: Pentony Enterprises LLC was compensated from non-controlling third party $15,000.00 for profile coverage. Pentony Enterprises LLC is not a registered investment advisers or broker/dealers. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.StockGuru.com is owned and operated by Pentony Enterprises LLC, 9555 Lebanon Road, Suite 103, Frisco, Texas 75035. Telephone: (214) 458-4258. Web: StockGuru.com. Email: Publisher@stockguru.com .

StockGuru.com is owned and operated by Pentony Enterprises LLC, 9555 Lebanon Road, Suite 103, Frisco, Texas 75035. Telephone: (214) 458-4258. Web: StockGuru.com. Email: Publisher@stockguru.com .

StockGuru News: CEO of ALR Technologies Sends Letter to Shareholders and Provides Future Outlook

Thursday, November 16th, 2006
CEO of ALR Technologies Sends Letter to Shareholders and Provides Future Outlook

ALR Technologies, Inc. (OTCBB: ALRT)

WINSTON-SALEM, NC–(MARKET WIRE)–Nov 16, 2006 — The following update is being released by ALR Technologies, Inc. (OTC BB:ALRT.OB – News). It is also available online at: http://www.alrt.com

I am pleased to have the opportunity to update you on ALRT’s progress at this exciting time in the company’s history. We have completed the long and arduous product development process and we are beginning our first full manufacturing run for delivery in January 2007.

Our product development process which included manufacturing, testing, and pilot programs with select groups has been an astounding success. Pilot programs have yielded significant compliance results that will correspond to better patient health outcome and health cost savings. Our ALRT500, recently branded the “Constant Health Companion(TM),” is now ready to fill a serious gap in current health management practices.

As with any growing company, we encountered a few challenges throughout the year which I believe we quickly addressed. We experienced a delay in the first full manufacturing run due to implementation of measures that will allow for a significant reduction in product cost. Our first full manufacturing run is in progress with shipments scheduled for January 2007. This delay has not impacted our sales or market penetration efforts as we have established strong industry relationships and are continuing to receive product orders. With this innovative product now available for sale and distribution we believe we will realize significant revenues as our marketing efforts increase.

Accomplishments

Our senior management team has made valuable strategic decisions over the course of this year and I am confident that, with the support and contributions of our shareholders, employees, and partners, we are on the verge of realizing the true potential of our products in the marketplace. The last ten months have been a period of transition for ALR Technologies, during which we have strategically positioned the company for long-term success. We are proud of our recent accomplishments, which include:

– completed the development of the company’s flagship product, the Constant Health Companion,

– established a partnership with PageMinder which resulted in Medicaid asthma patients to utilize our system,

– received successful compliance results for a patient living with the life-saving procedure of a heart transplant by using our Constant Health Companion, and

– received national market recognition from the Behavioral Health Community for the Constant Health Companion’s positive health and financial impact on individuals with disabilities.

The Future

Looking to the immediate future, we are very encouraged with our progress and growth prospects. There are three key highlights to our business strategy:

– Roll out of a multi-faceted marketing campaign starting in the first quarter of 2007. Advertising and marketing will be key areas of focus for ALR Technologies. By creating awareness that our Constant Health Companion is now available, we believe that we will quickly gain significant attention from health insurance payers. We expect these initiatives, along with the efforts to expand our sales force, will significantly drive sales in the near future.

– We are addressing the debt on our balance sheet. We realize we are in need of additional funding to meet our future growth plans. We are speaking with several potential funding prospects that could help us with near term and long term funding needs.

– Continue to focus on R&D to include developing next generation products as the market demands. We have already identified some key additions to our Constant Health Companion system that will extend our reach into complimentary markets and into the health management marketplace. We plan to allocate significant resources in the future to strongly pursue these developmental efforts.

Financial Outlook

Based on order flow and commitments that we have received to date, we are projecting our sales for the fiscal year 2007 to be in the range of $4.5 to $5 million. This number does not take into consideration any new sales in-roads from this point on. This would be a significant jump from our current levels due to our main product being commercially available starting January 2007.

I would like to thank our shareholders for their continued support. I expect to see significant value growth in ALR Technologies for our shareholders as we begin to drive sales.

Sincerely,
Sidney Chan
Chief Executive Officer
ALR Technologies, Inc.

About ALR Technologies

ALR Technologies Inc., which specializes in health and disease management products and services, designs and manufactures medication compliance products and compliance home-monitoring and intervention systems to meet the needs for several targeted user groups.

To learn more about ALR Technologies, download the latest version of our corporate profile from http://www.alrt.com/Our%20Company/investor.html

More information on the Constant Health Companion home compliance system can be found at www.alrt.com/products/alrt500.html

More on ALR Technologies at http://www.alrt.com

This release contains certain “forward-looking statements” relating to ALR Technologies business, and these statements reflect the current views of ALR Technologies with respect to future events and are subject to certain risks, uncertainties and assumptions. When used, the words “estimate,” “expect,” “anticipate,” “believe” and similar expressions are intended to identify such forward-looking statements. There are many factors that could cause the actual results, performance or achievements of ALR Technologies and its products to be materially different from any future results, performances or achievements that may be expressed or implied by such forward-looking statements. Further management discussions of risks and uncertainties can be found in the company’s quarterly filings with the Securities Exchange Commission.

Contact:

Public and Investor Relations:
Mercom Capital Group, llc
Tel: 1.512.828.6645
E-mail: Email Contact

Source: ALR Technologies, Inc.

View the StockGuru Profile for ALR Technologies:

http://www.stockguru.com/profiles/alrt/

We Invite you to Visit the All New StockGuru Blog!

Here you will find updates on all our covered companies, including Profiled Companies and StockGuru Picks.

Click HERE to visit the Blog, or go to:

http://stockguru.com/blog/

StockGuru.com is owned and operated by Pentony Enterprises LLC, 9555 Lebanon Road, Suite 103, Frisco, Texas 75035. Telephone: (214) 458-4258. Web: StockGuru.com. Email: Publisher@stockguru.com. Disclosure: Pentony Enterprises LLC was compensated $15,000 from a non-controlling third party for profile coverage. Pentony Enterprises LLC is not a registered investment adviser or broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.

StockGuru Blog: ALR Technologies — Constant Health Companion

Wednesday, November 15th, 2006
ALRTALR Technologies, Inc.
Stock Guru Profile ALR Technologies Inc. (ALRT – OTCBB)

ALR Technology’s Constant Health Companion(TM) formerly known as the ALRT500 system was the first in the US to provide an affordable, portable, and easy to use combination of reminding caregivers or patients to take medications or treatments as well as allowing for remote monitoring by healthcare professionals or family members.

ALRT’s products and services cost to the consumer is more than 50% lower than the next least expensive system.

Studies have proven that the cost of medication non-compliance is great both in terms of health and dollars. The consequence can be death or loss of an organ transplant. These are very serious consequences for the individual and society. Organ transplant is expensive and there are an inadequate number of organs for transplant.

Compliance is defined as a customer filling his/her prescription and taking the correct dose at the correct time.

Economic costs include the fact that payors must reimburse patients for unused medication, and pay again to help patients who did not take their medication and this can include serious relapse and organ rejection.

Unnecessary illness and death is common: a U.S. estimate indicates 125,000 cardiovascular deaths result from non-compliance annually.

The Constant Health Companion system which has been in the development process for five years is now in its second production run and receiving acceptance from the healthcare community.

The Constant Health Companion system provides caregivers the ability to determine a patient’s compliance and allows intervention when a patient is non-compliant which results in short and long term cost savings.

There are many organizations that will benefit from medication compliance. These industries will have the ability to generate definable cost savings with the implementation of medication compliance products.

Disease Management Devices are important to Homecare Providers, Health Insurance Providers, Insurance Payors which include corporations with self insured plans, Pharmaceutical companies, Retail Consumers, and Veterinary Pharmaceutical.

Insurance providers will have the ability to monitor plan members’ compliance and adjust the pricing of their coverage based on adherence of the chronic care members. This will result in the realization of significant return on investment (ROI).

Primary Conditions Served and Benefit by Medication Compliance

Patients with the following chronic conditions can benefit from ALR compliance reminder services:

Chronic Obstructive Pulmonary Disease, Organ Transplant, Mental Health, HIV / AIDS, Congestive Heart failure, Coronary Artery Disease, Diabetes, Parkinson’s disease, Alzheimer’s disease, or anyone with disease or health management regimen, whether it’s only for a four day course of antibiotics, a 16 week injury recovery program, or a long term medication and diagnostic regimen.

With ALRT’s products and services cost to the consumer more than 50% lower than the next least expensive system the choice seems obvious!

ALR Technologies Power Point Presentation.

Page Minder Report

Source: ALR Technologies, M2 Communications, and Page Minder

Wendy Prabhu, Investor Relations for ALR Technologies, Inc.
Phone: (512) 828-6645
Email: http://www.stockguru.com/blog/alrt@mercomcapital.com

Sidney Chan, CEO
ALRTALR Technologies, Inc.
114M Reynolda Village
Winston-Salem, NC 27106
Website: http://www.alrt.com
Phone: (336) 722-2254

SOURCE: ALR Technologies, Inc. and New England Journal of Medicine and Managed Healthcare Executive; Sep2006, Vol. 16 Issue 9, p44-51, 4p

Safe Harbor and Forward Looking Statement:Certain statements set forth in this article constitute “forward-looking statements.” Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance or achievements. Such statements are not guarantees of future performance and are subject to risks and uncertainties that could cause the company’s actual results and financial position to differ materially from those included within the forward-looking statements, including the Company’s ability to obtain sufficient financing to fund both its internal growth opportunities and acquisition strategy. More information about the potential risks and factors that could affect the Company’s business and financial results is included in the Company’s filings, available via the United States Securities and Exchange Commission at http://www.sec.gov/.

Disclosure: Pentony Enterprises LLC was compensated from non-controlling third party $15,000.00 for profile coverage. Pentony Enterprises LLC is not a registered investment advisers or broker/dealers. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.StockGuru.com is owned and operated by Pentony Enterprises LLC, 9555 Lebanon Road, Suite 103, Frisco, Texas 75035. Telephone: (214) 458-4258. Web: StockGuru.com. Email: Publisher@stockguru.com .

StockGuru.com is owned and operated by Pentony Enterprises LLC, 9555 Lebanon Road, Suite 103, Frisco, Texas 75035. Telephone: (214) 458-4258. Web: StockGuru.com. Email: Publisher@stockguru.com .

StockGuru Blog: ATSI Communications, Inc. — Beats the Big Boys!

Friday, November 10th, 2006

ATSXATSI Communications, Inc.
Stock Guru Profile ATSI Communications, Inc. (ATSX – OTCBB)

ATSI Communications, Inc. operates through its two wholly owned subsidiaries, Digerati Networks, Inc. and Telefamilia Communications, Inc.

I would invite you to review ATSX’s chart:

Market Cap (intraday): 5.59M
Enterprise Value (10-Nov-06)3 6.88M

But here’s the story of a company that’s on the move:

Quarterly Revenue Growth (year over year) is 188.2o percent when the industry average is: 12.40%

Let’s look at the same revenue growth for the big carriers: AT&T: 51.80%; Telefonos de Mexico: 0.50%; Verizon: 25.80%.

There’s a story here and it’s simple. Telefonos de Mexico is not keeping its market once they move to the U.S. AT&T and Verizon cannot be as nimble as ATSX.

ATSX understands its international market. It’s located in San Antonio. ATSX does not view the Hispanic market as one mass entity but understands there are entities within the Hispanic market and addresses each one.

ATSX is the real giant here, they are the quiet giant that is established and in place and appealing to the largest growth market in the international industry: the U.S. to Mexico telecom corridor.

We will be examining the reason for this company’s steady growth and strong technicals in the coming days.

Source: ATSI Communications, Inc. and Yahoo Finance

Arthur L. Smith
President and Chief Executive Officer
ATSI Communications, Inc.
3201 Cherry Ridge Drive
Suite C-300
San Antonio, Texas 78230
Phone: 210.614.7240
Fax: 210.614.7264

Disclosure: Pentony Enterprises LLC was compensated $18,000 by the company for profile coverage. Pentony Enterprises is not a registered investment advisers or a broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person, or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.

Safe Harbor and Forward Looking Statement:Certain statements set forth in this article constitute “forward-looking statements.” Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance or achievements. Such statements are not guarantees of future performance and are subject to risks and uncertainties that could cause the company’s actual results and financial position to differ materially from those included within the forward-looking statements, including the Company’s ability to obtain sufficient financing to fund both its internal growth opportunities and acquisition strategy. More information about the potential risks and factors that could affect the Company’s business and financial results is included in the Company’s filings, available via the United States Securities and Exchange Commission at http://www.sec.gov/.

StockGuru.com is owned and operated by Pentony Enterprises LLC, 9555 Lebanon Road, Suite 103, Frisco, Texas 75035. Telephone: (214) 458-4258. Web: StockGuru.com. Email: Publisher@stockguru.com .

StockGuru Blog: ALR Technologies, Inc. – ALRT 500 Production Run in Active Sales

Monday, November 6th, 2006
ALRTALR Technologies, Inc.
Stock Guru Profile ALR Technologies Inc. (ALRT – OTCBB)

ALR Technologies is focusing on the ALRT500 Home Health System. This is a medication and treatment compliance and monitoring system. This product comes with a compliance monitoring system which provides internet communications regarding a patient’s compliance. Family members who cannot be with a loved one 24/7 can be certain they are complying with their doctor’s orders. This works for family members who live next door, or in the next state or in another country.

ALR Technologies has received orders for the ALRT500 system and has sold one production run with more orders to fill. Another production run is underway and delivery from this production is expected in January.

ALR Technologies expects to have the entire first full production run sold before the manufactured product is ready for delivery in January. ALR Technologies now planning our second full production run and making plans for expanded capacity of manufacturing. 2007 will be expected to be the company’s first year with solid sales of the ALRT500 system. Right now, they are discussing releasing projections – but have not yet made a firm commitment to do so.

Previous years sales have been all from ALRT ancillary products.

ALR Technologies tells their story through Power Point and Stock Guru has brought that Power Point to you. For a one stop cohesive look at what ALRT is doing and how they are doing it: Link Here.

Health care management is a new segment of the healthcare industry. Healthcare management is recognized as being cost effective because ultimate it conserves precious healthcare resources across the board.

ALR Technologies Power Point Presentation.

Stay tuned for more on this company as we look at the recurring and regenerative revenue stream provided by this system: Everyone knows that Cingular does not generate its serious revenue from the sale of cell phones but rather from the service it provides. ALR Technologies will generate revenue in this same fashion.

Source: ALR Technologies

Wendy Prabhu, Investor Relations for ALR Technologies, Inc.
Phone: (512) 828-6645
Email: http://www.stockguru.com/blog/alrt@mercomcapital.com

Sidney Chan, CEO
ALRTALR Technologies, Inc.
114M Reynolda Village
Winston-Salem, NC 27106
Website: http://www.alrt.com
Phone: (336) 722-2254

SOURCE: ALR Technologies, Inc. and New England Journal of Medicine and Managed Healthcare Executive; Sep2006, Vol. 16 Issue 9, p44-51, 4p

Safe Harbor and Forward Looking Statement:Certain statements set forth in this article constitute “forward-looking statements.” Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance or achievements. Such statements are not guarantees of future performance and are subject to risks and uncertainties that could cause the company’s actual results and financial position to differ materially from those included within the forward-looking statements, including the Company’s ability to obtain sufficient financing to fund both its internal growth opportunities and acquisition strategy. More information about the potential risks and factors that could affect the Company’s business and financial results is included in the Company’s filings, available via the United States Securities and Exchange Commission at http://www.sec.gov/.

Disclosure: Pentony Enterprises LLC was compensated from non-controlling third party $15,000.00 for profile coverage. Pentony Enterprises LLC is not a registered investment advisers or broker/dealers. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.

Disclosure: StockGuru.com is owned and operated by Pentony Enterprises LLC, 9555 Lebanon Road, Suite 103, Frisco, Texas 7503. Telephone: (214) 458-4258. Web: StockGuru.com. Email: Publisher@stockguru.com.